Stanley-Laman Group, Ltd. - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 149 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q2 2015$221,000
+8.9%
5,2390.0%0.04%
+8.1%
Q1 2015$203,000
-23.4%
5,239
-27.0%
0.04%
-19.6%
Q1 2014$265,000
-3.6%
7,1760.0%0.05%
-23.3%
Q4 2013$275,0007,1760.06%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q1 2015
NameSharesValueWeighting ↓
PSquared Asset Management AG 171,495$7,410,00032.67%
Newport Asia LLC 714,600$30,877,00012.95%
Coupland Cardiff Asset Management LLP 45,000$1,944,0006.29%
NINE MASTS CAPITAL Ltd 525,985$22,730,0005.83%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,694,589$116,433,0005.17%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 220,131$9,512,0004.79%
Sensato Investors LLC 549,341$23,737,0004.44%
Grandeur Peak Global Advisors, LLC 396,743$17,143,0003.83%
Taconic Capital Advisors LP 2,150,000$92,902,0003.43%
Central Asset Investments & Management Holdings (HK) Ltd 68,815$2,973,0003.26%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders